Name the outcome first

A study may measure a laboratory value, a scan, symptoms, hospital admissions or survival. These outcomes answer different questions. Before reading the result, write down exactly what was measured.

Why researchers use intermediate measures

Some outcomes take years to observe. A quicker measurement can make a study feasible and help explore a mechanism. Whether it reliably predicts a patient benefit must be established; a plausible explanation alone is not enough.

Keep the claim within the measurement

A change in a biomarker should be described as a change in that biomarker. Improvement in a symptom score should not quietly become a claim about longer survival. This distinction makes a result more useful, not less interesting.

A useful reading checklist

Find the prespecified primary outcome, the follow-up period and the comparison. Then look at adverse effects and missing data. If several outcomes were tested, ask how the analysis accounted for multiple comparisons.

LIMITATIONS

Limits of this interpretation

  • The relevance of a surrogate depends on its validation in the particular setting.
SOURCE NOTES

Sources & transparency

    This is an original educational explainer. Its worked examples are illustrative and do not describe a clinical trial.

    Prepared with AI assistance. Worked examples are illustrative, not estimates of personal medical risk.

    Clinical review: Not applicable to this educational guide

    Suggest a correction
    WORDS BEHIND THE RESEARCH

    A quick reference

    Look up a term, work through an example and check a common pitfall.

    Biomarker Surrogate endpoint Composite endpoint